Versant Venture Capital III, L.P.
CIK 0001456586 Name as filed on the most recent filing
Filed as Versant Venture Capital III, L.P. (8)
19 transaction lines · from 8 filings · filed 2010-08-10 to 2016-06-10 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Flexion Therapeutics Inc 2 filings
- ISSUER Phaserx, Inc. 1 filings
- ISSUER Ocular Therapeutix, Inc 2 filings
- ISSUER Opgen Inc 1 filings
- ISSUER Immune Design Corp. 1 filings
- ISSUER Trius Therapeutics Inc 1 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2016-06-08 |
Flexion Therapeutics Inc FLXN |
P, Open-market purchase | 710,091 acquired | 14.00 | 9,941,274.00 | Form 4, filing 0001104659-16-126659 | |
| 2016-06-08 |
Flexion Therapeutics Inc FLXN |
P, Open-market purchase | 4,194 acquired | 14.00 | 58,716.00 | Form 4, filing 0001104659-16-126659 | |
| 2016-05-23 |
Phaserx, Inc. PZRX |
S, Open-market sale | 182,914 disposed | 0.01 | 1,829.14 | Form 4, filing 0001144204-16-104556 | |
| 2016-05-23 |
Phaserx, Inc. PZRX |
S, Open-market sale | 73,615 disposed | 0.01 | 736.15 | Form 4, filing 0001144204-16-104556 | |
| 2016-05-23 |
Phaserx, Inc. PZRX |
S, Open-market sale | 1,080 disposed | 0.01 | 10.80 | Form 4, filing 0001144204-16-104556 | |
| 2016-05-23 |
Phaserx, Inc. PZRX |
S, Open-market sale | 435 disposed | 0.01 | 4.35 | Form 4, filing 0001144204-16-104556 | |
| 2016-05-23 |
Phaserx, Inc. PZRX |
P, Open-market purchase | 596,477 acquired | 5.00 | 2,982,385.00 | Form 4, filing 0001144204-16-104556 | |
| 2016-05-23 |
Phaserx, Inc. PZRX |
P, Open-market purchase | 3,523 acquired | 5.00 | 17,615.00 | Form 4, filing 0001144204-16-104556 | |
| 2015-06-15 |
Ocular Therapeutix, Inc OCUL |
S, Open-market sale | 318,122 disposed | 22.00 | 6,998,684.00 | Form 4, filing 0001209191-15-053412 | |
| 2015-06-15 |
Ocular Therapeutix, Inc OCUL |
S, Open-market sale | 1,878 disposed | 22.00 | 41,316.00 | Form 4, filing 0001209191-15-053412 | |
| 2015-06-10 |
Ocular Therapeutix, Inc OCUL |
S, Open-market sale | 424,494 disposed | 22.00 | 9,338,868.00 | Form 4, filing 0001209191-15-052367 | |
| 2015-06-10 |
Ocular Therapeutix, Inc OCUL |
S, Open-market sale | 2,506 disposed | 22.00 | 55,132.00 | Form 4, filing 0001209191-15-052367 | |
| 2015-05-08 |
Opgen Inc OPGNOPGNW |
P, Open-market purchase | 410,906 acquired | 6.00 | 2,465,436.00 | Form 4, filing 0001140361-15-019195 | |
| 2015-05-08 |
Opgen Inc OPGNOPGNW |
P, Open-market purchase | 2,426 acquired | 6.00 | 14,556.00 | Form 4, filing 0001140361-15-019195 | |
| 2014-07-29 |
Immune Design Corp. IMDZ |
S, Open-market sale | 208,334 disposed | 12.00 | 2,500,008.00 | Form 4, filing 0001123292-14-000785 | |
| 2014-07-29 |
Immune Design Corp. IMDZ |
P, Open-market purchase | 233,333 acquired | 12.00 | 2,799,996.00 | Form 4, filing 0001123292-14-000785 | |
| 2014-02-18 |
Flexion Therapeutics Inc FLXN |
P, Open-market purchase | 305,886 acquired | 13.00 | 3,976,518.00 | Form 4, filing 0001209191-14-012247 | |
| 2014-02-18 |
Flexion Therapeutics Inc FLXN |
P, Open-market purchase | 1,806 acquired | 13.00 | 23,478.00 | Form 4, filing 0001209191-14-012247 | |
| 2010-08-06 |
Trius Therapeutics Inc TSRX |
P, Open-market purchase | 914,529 acquired | 5.00 | 4,572,645.00 | Form 4, filing 0001181431-10-041137 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Versant Venture Capital III, L.P., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001456586
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6